CME Group Inc. $CME Shares Sold by EDENTREE ASSET MANAGEMENT Ltd

EDENTREE ASSET MANAGEMENT Ltd lessened its stake in CME Group Inc. (NASDAQ:CME) by 10.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 26,138 shares of the financial services provider’s stock after selling 2,967 shares during the period. CME Group accounts for about 1.7% of EDENTREE ASSET MANAGEMENT Ltd’s holdings, making the stock its 21st biggest position. EDENTREE ASSET MANAGEMENT Ltd’s holdings in CME Group were worth $7,060,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in CME. Caldwell Trust Co increased its holdings in shares of CME Group by 116.3% in the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 50 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new position in CME Group in the 3rd quarter valued at $27,000. Financial Consulate Inc. acquired a new position in CME Group in the 3rd quarter valued at $28,000. Sagard Holdings Management Inc. purchased a new position in CME Group during the 2nd quarter worth $30,000. Finally, Corundum Trust Company INC acquired a new stake in shares of CME Group in the 3rd quarter worth $30,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME’s formal announcement to offer 24/7 trading for crypto futures and options — a move that addresses the timing gap with always‑on spot crypto markets and could lift ADV and fee revenue; the company cited record crypto notional volume in 2025. CME Group to Launch 24/7 Cryptocurrency Futures and Options Trading on May 29
• Positive Sentiment: Widespread coverage emphasizes the practical impacts — continuous trading can reduce “CME gaps,” boost institutional flow and expand crypto derivatives ADV, supporting the bullish thesis for trading‑fee growth. CME targets May launch for 24/7 crypto derivatives trading
• Positive Sentiment: Analyst/fin‑media bullishness — some outlets include CME among top picks, arguing the firm converts market volatility into trading revenue, which supports the stock’s rally. 2 Best Stocks to Buy Right Now for February
• Neutral Sentiment: Macro/market context — broader market moves (small‑cap rotation and sector flows) could be influencing intraday moves in financials/exchanges but are not specific to CME’s fundamentals. Small Caps Stage Quiet Comeback As AI Trade Shows Cracks
• Neutral Sentiment: Reported short‑interest data appears immaterial or inconsistent (no meaningful change reported); it isn’t currently signaling a large positioning risk.
• Negative Sentiment: Insider selling — director Martin J. Gepsman sold 300 shares; small in size but noteworthy as a disclosed insider sale. Insider Sale: Martin J. Gepsman
• Negative Sentiment: Critical takeaways — at least one outlet warns of risks to the CME thesis (valuation and competitive/operational risks), which could temper enthusiasm if amplified by further negative coverage. 2 Reasons CME is Risky and 1 Stock to Buy Instead

CME Group Trading Up 1.4%

Shares of CME stock opened at $308.09 on Friday. The stock has a market cap of $111.10 billion, a P/E ratio of 27.61, a P/E/G ratio of 3.60 and a beta of 0.27. The company has a quick ratio of 1.02, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group Inc. has a fifty-two week low of $246.91 and a fifty-two week high of $309.35. The business has a fifty day simple moving average of $283.19 and a 200-day simple moving average of $274.78.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.64 billion. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The firm’s revenue was up 8.1% on a year-over-year basis. During the same period in the prior year, the company earned $2.52 EPS. On average, analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, March 10th will be given a dividend of $1.30 per share. The ex-dividend date is Tuesday, March 10th. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. This is an increase from CME Group’s previous quarterly dividend of $1.25. CME Group’s payout ratio is presently 44.80%.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Raymond James Financial cut their price target on shares of CME Group from $311.00 to $310.00 and set an “outperform” rating for the company in a report on Wednesday, February 4th. JPMorgan Chase & Co. raised their price target on CME Group from $262.00 to $266.00 and gave the company an “underweight” rating in a report on Thursday, February 5th. Piper Sandler lifted their price target on CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Argus cut their price objective on CME Group from $308.00 to $295.00 in a research report on Friday, October 31st. Finally, Bank of America raised their target price on CME Group from $201.00 to $209.00 in a report on Wednesday, December 10th. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $299.53.

Insider Buying and Selling

In other news, Director Dennis Suskind sold 748 shares of the company’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $300.00, for a total value of $224,400.00. Following the sale, the director directly owned 2,699 shares in the company, valued at $809,700. This represents a 21.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $305.90, for a total value of $91,770.00. Following the sale, the director owned 24,999 shares of the company’s stock, valued at approximately $7,647,194.10. This represents a 1.19% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 26,048 shares of company stock worth $7,054,920 in the last quarter. Corporate insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.